Transfusion-associated graft versus host disease medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Transfusion-associated graft versus host disease}} {{CMG}} ==Overview== ==Medical Therapy== '''Treatment''' is only supportive, as no available form of therapy has...")
 
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{Transfusion-associated graft versus host disease}}
{{Transfusion-associated graft versus host disease}}
{{CMG}}
{{CMG}}
Line 13: Line 15:
[[Category:Transfusion medicine]]
[[Category:Transfusion medicine]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Needs content]]

Latest revision as of 19:15, 21 September 2012

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Transfusion-associated graft versus host disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transfusion-associated graft versus host disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Biomarker Panel

Chest X Ray

HLA analysis

Skin Punch Biopsy

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transfusion-associated graft versus host disease medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transfusion-associated graft versus host disease medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transfusion-associated graft versus host disease medical therapy

CDC on Transfusion-associated graft versus host disease medical therapy

Transfusion-associated graft versus host disease medical therapy in the news

Blogs on Transfusion-associated graft versus host disease medical therapy

Directions to Hospitals Treating Transfusion-associated graft versus host disease

Risk calculators and risk factors for Transfusion-associated graft versus host disease medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

Treatment is only supportive, as no available form of therapy has proven effective in treating TA-GvHD.

References

Template:WH Template:WS